Related Experiment Video
Updated: Mar 22, 2026
05:12
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
1.6K
[How Treatable is Vascular Dementia?]
1Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku University Graduate School of Medicine.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|April 9, 2016
Summary
Vascular dementia, the second most common dementia, is preventable and treatable through managing cerebrovascular disease risk factors. However, clear diagnostic criteria and effective symptomatic treatments remain elusive.
Area of Science:
- Neurology
- Gerontology
- Public Health
Context:
- Vascular dementia is a significant cause of cognitive decline, second only to Alzheimer's disease.
- Understanding the link between cerebrovascular disease and dementia is crucial for public health.
- Diagnostic challenges and overlapping pathologies complicate research and treatment.
Purpose:
- To clarify the concept of vascular dementia and its current research landscape.
- To assess the treatability of vascular dementia based on existing evidence.
- To review the status of clinical trials and therapeutic interventions.
Summary:
- Vascular dementia results from brain changes due to cerebrovascular disease, presenting diagnostic uncertainties and classification issues.
- While preventable and treatable via vascular risk factor management, established symptomatic treatments are lacking.
- Current clinical trials show limited cognitive benefits from cholinesterase inhibitors and memantine; rehabilitation and exercise show potential but require more evidence.
Impact:
- Highlights the need for standardized diagnostic criteria for vascular dementia.
- Emphasizes the importance of primary and secondary prevention strategies for cerebrovascular diseases.
- Identifies gaps in current treatment options and suggests areas for future research, including rehabilitation and exercise interventions.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:30Dementia
672
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
672
01:26Atherosclerosis III: Management
573
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
573
01:29Venous Thrombosis III: Interprofessional Care
459
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
01:27Peripheral Artery Disease III: Interprofessional Care
543
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
543